Clinical trials
Observational Multiple Endocrine Neoplasia Type 1 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2013 | 3 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 4 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bar-Chama, Natan, M.D. | 1 |
| Freeman-Sheldon Research Group, Inc. | 1 |
| Jersey Shore University Medical Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Sanford Health | 1 |
| St. Jude Children's Research Hospital | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
| University of Colorado, Denver | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Endocrine Neoplasia Type 1 | 10 |
| Multiple Endocrine Neoplasia | 2 |
| Multiple Endocrine Neoplasia Type 2a | 2 |
| Pancreatic Neoplasms | 2 |
| Addison Disease | 1 |
| Adenomatous Polyposis Coli | 1 |
| Adrenocortical Carcinoma | 1 |
| Alagille Syndrome | 1 |
| Alstrom Syndrome | 1 |
| Amnesia, Transient Global | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.